Related Experiment Video
Updated: Mar 20, 2026
05:31
Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
Published on: June 8, 2022
3.5K
Transcatheter Aortic Valve Replacement: A Solution for the Young, Inoperable and Regurgitant
Kamran Majeed1, Andrew J Lucking1, Ross L Roberts-Thomson1
1Cardiovascular Investigation Unit, Royal Adelaide Hospital, Adelaide, SA, Australia.
Heart, Lung & Circulation
|June 7, 2016
Summary
Transcatheter aortic valve replacement (TAVR) is a proven treatment for severe aortic stenosis. Off-label TAVR use, like in a young patient with severe aortic regurgitation, requires a multidisciplinary team and thorough patient engagement.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
Background:
- Transcatheter aortic valve replacement (TAVR) is established for severe aortic stenosis in high-risk patients.
- Technological advancements and increased experience have broadened TAVR eligibility.
- Off-label TAVR applications necessitate careful evaluation and monitoring.
Observation:
- A case of an inoperable 24-year-old male with severe aortic regurgitation (AR) is presented.
- This case explores the potential for TAVR in younger, inoperable patients with AR.
- The challenges and considerations for extending TAVR to non-standard indications are highlighted.
Findings:
- Successful TAVR in this young, inoperable patient with severe AR was achieved.
- The case underscores the importance of a comprehensive, multidisciplinary team approach.
- Early and extensive patient and family communication is crucial for off-label TAVR.
Implications:
- TAVR may be a viable option for select inoperable younger patients with severe AR.
- Multidisciplinary team expertise is essential for managing complex and off-label TAVR cases.
- Robust patient and family engagement is paramount before considering off-label TAVR procedures.
Keywords:
Aortic regurgitationAortic stenosisOff-label indicationsTranscatheter Aortic Valve Replacement (TAVR)More Related Videos
Related Concept Videos
01:25Aortic Regurgitation III: Medical Management
540
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
540
01:17Aortic Regurgitation IV: Nursing Management
392
A nurse managing a patient with aortic regurgitation begins with a comprehensive assessment, including a review of the patient's medical history, family history, and lifestyle factors. During the cardiac examination, the nurse listens for heart sounds and checks for signs of valve abnormalities. The nurse also observes for symptoms such as dyspnea, orthopnea, and paroxysmal nocturnal dyspnea and assesses the patient's endurance and daily activity tolerance.Based on the findings, the nurse...
392
01:15Aortic Regurgitation I: Introduction
1.1K
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
1.1K
01:25Mitral Regurgitation III: Medical Management
512
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
512
01:26Mitral Stenosis III: Medical Management
423
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
423
01:22Aortic Regurgitation II: Clinical Features and Diagnostic Tests
824
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
824